Organization
Beijing Luzhu Biotechnology
2 clinical trials
Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety, and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Subjects Aged 40 Years and OlderStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine (LZ901) in Subjects Aged 50 to 70 Years InclusiveStatus: Recruiting, Estimated PCD: 2024-02-01